Howard Lee Selected Research

Howard Lee Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 09/2003
9	Hypertension (High Blood Pressure) 01/2023 - 10/2011
7	Body Weight (Weight, Body) 01/2020 - 03/2005
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 06/2014
3	Obesity 01/2023 - 12/2006
3	Rheumatoid Arthritis 01/2020 - 04/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 11/2009 - 12/2006
3	Deglutition Disorders (Dysphagia) 04/2008 - 01/2007
2	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2019
2	Neutropenia 03/2022 - 08/2014
2	COVID-19 05/2021 - 12/2020
2	Constipation 01/2021 - 01/2021
2	Gout 11/2019 - 01/2015
2	Liver Neoplasms (Liver Cancer) 05/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 12/2016 - 10/2016
2	Cardiotoxicity 05/2015 - 05/2015
2	Infections 01/2014 - 12/2008
2	Dizziness (Lightheadedness) 10/2013 - 10/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024
1	Tumor Lysis Syndrome 01/2024
1	Diabetes Mellitus 12/2023
1	Hypersensitivity (Allergy) 02/2023
1	Lymphopenia (Lymphocytopenia) 12/2022
1	Peptic Ulcer (Peptic Ulcers) 01/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Gaucher Disease (Gaucher's Disease) 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Diarrhea 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 10/2018
1	Radiation Pneumonitis 09/2017
1	Malignant Mesothelioma 09/2017
1	Hepatitis B 05/2017
1	Hepatitis C 05/2017
1	Human Influenza (Influenza) 01/2017

Drug/Important Bio-Agent (IBA)

4	fimasartanIBA 09/2013 - 10/2011
4	BariumIBA 04/2008 - 01/2007
3	GC1118IBA 12/2023 - 01/2019
3	Monoclonal AntibodiesIBA 01/2021 - 09/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 11/2009
2	VaccinesIBA 05/2021 - 12/2020
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2021
2	YH12852IBA 01/2021 - 01/2021
2	Biosimilar PharmaceuticalsIBA 01/2020 - 01/2014
2	Infliximab (Remicade)FDA Link 01/2020 - 01/2014
2	CT-P13IBA 01/2020 - 01/2014
2	Uric Acid (Urate)IBA 11/2019 - 01/2015
2	TabletsIBA 01/2015 - 10/2013
2	LC15-0444IBA 01/2015 - 06/2014
2	Valsartan (Vals)FDA Link 01/2014 - 09/2013
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2014 - 12/2008
2	Etanercept (Enbrel)FDA Link 03/2005 - 04/2003
1	SteroidsIBA 01/2024
1	SodiumIBA 12/2023
1	Fluorouracil (Carac)FDA LinkGeneric 12/2023
1	Leucovorin (Folinic Acid)FDA Link 12/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2023
1	Antineoplastic Agents (Antineoplastics)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2023
1	Immunoglobulin E (IgE)IBA 02/2023
1	Penicillins (Penicillin)FDA Link 02/2023
1	dulaglutideIBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Interleukin-7 (Interleukin 7)IBA 12/2022
1	eflapegrastimIBA 03/2022
1	PotassiumIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	AcidsIBA 01/2022
1	eupatilinIBA 01/2022
1	YH4808IBA 01/2022
1	methylamphotericin B (AME)IBA 01/2021
1	prucaloprideIBA 01/2021
1	apremilastIBA 01/2021
1	Phosphodiesterase 4 InhibitorsIBA 01/2021
1	LeptinIBA 01/2020
1	AdiponectinIBA 01/2020
1	URC102IBA 11/2019
1	AntibodiesIBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2019
1	EpitopesIBA 01/2019
1	LigandsIBA 01/2019
1	Thioctic Acid (Lipoic Acid)IBA 10/2018
1	Pregabalin (Lyrica)FDA Link 10/2018
1	Protons (Proton)IBA 09/2017
1	Carboxylesterase (Hydrolase S)IBA 01/2017

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2024 - 09/2003
12	Therapeutics 12/2023 - 01/2005
2	Radiotherapy 11/2023 - 09/2017
2	Aftercare (After-Treatment) 05/2016 - 11/2009
1	Remission Induction 01/2024
1	Ambulatory Care (Outpatient Care) 01/2023
1	Oral Administration 01/2021
1	Intravenous Infusions 01/2021
1	Proton Therapy 09/2017
1	Transplantation 05/2017